SciELO - Scientific Electronic Library Online

 
vol.15 issue3Assessment of health seeking behaviour and self-medication among general public in the state of Penang, MalaysiaThe impact of drug related problems on health-related quality of life among hypertensive patients in Jordan author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Pharmacy Practice (Granada)

On-line version ISSN 1886-3655Print version ISSN 1885-642X

Abstract

MAYYAS, Fadia; IBRAHIM, Khalid  and  ALZOUBI, Karem H.. Awareness of physicians and pharmacists of aldosterone antagonists in heart failure and myocardial infarction in Jordan. Pharmacy Pract (Granada) [online]. 2017, vol.15, n.3, 994. ISSN 1886-3655.  https://dx.doi.org/10.18549/pharmpract.2017.03.994.

Objective:

to evaluate physicians and clinical pharmacists’ awareness and practices regarding use of aldosterone antagonists in heart failure (HF) and post-myocardial infarction (MI).

Methods:

First, we reviewed the prescription of aldosterone antagonists among 408 patients presenting to the cardiology clinic at a major hospital in Jordan. Second, physicians and pharmacists working in cardiovascular departments completed a questionnaire related to use of aldosterone antagonists in HF and post-MI.

Results:

Thirty patients (7.59%) were eligible for aldosterone antagonist; only 4 received them at discharge (13.3%). The survey was completed by 153 professionals (response rate 76.12%). About 72.1% of participants were aware of studies regarding use of aldosterone antagonists post-MI and in HF. Moreover, 10.45%/53.6% of participants strongly agreed/agreed that these agents are useful in normotensive post-MI and HF patients. Spironolactone was the most prescribed drug by 92.1% of participants. About 41.8% of participants reported use of spironolactone in post-MI and HF. With respect to guidelines, only 39.2% of participants agreed that adding spironolactone to standard therapy in HF is recommended, and 48.3% agreed on adding it directly post-MI. Clinical pharmacists and cardiologists were generally more aware of guidelines than pharmacists, cardiac surgeons and residents/fellows.

Conclusions:

there is an under-use of aldosterone antagonists in HF and post-MI patients, and a lack of detailed awareness of current guidelines among health care providers. Dissemination of evidence-based guidelines and usage protocols may improve management of post-MI and HF.

Keywords : Health Knowledge; Attitudes; Practice; Pharmacists; Physicians; Mineralocorticoid Receptor Antagonists; Heart Failure; Myocardial Infarction; Clinical Audit; Surveys and Questionnaires; Jordan.

        · text in English     · English ( pdf )